HCPCS Level II
J1571
Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
Codes near J1571
These sit next to J1571 in the CMS Level II file. All J codes
- J1562Injection, immune globulin (vivaglobin), 100 mg
- J1566Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
- J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1569Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg
- J1570Injection, ganciclovir sodium, 500 mg
- J1572Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1573Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
- J1574Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
- J1575Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
- J1576Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 49591-0051-51 | Hepagam B | Kamada Ltd. | 10 |
| 49591-0052-51 | Hepagam B | Kamada Ltd. | 2 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.